SCHEMBL8235202

SCHEMBL8235202

CN(C)CCNC(=O)c1cccc(-c2ccc(CN3CC(c4ccccc4)OC3=O)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 5/20 0.46
CHRM4 P08173 1/20 0.45
CAMK2D Q13557 1/20 0.43
PARP1 P09874 4/20 0.43
FADS1 O60427 1/20 0.43
FYN P06241 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
RAD52 P43351 1/20 0.42
PDE1A P54750 1/20 0.41
PDE1B Q01064 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE7A Q13946 1/20 0.41
PDE1C Q14123 1/20 0.41
UTS2R Q9UKP6 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13086151 1.00 GRM2 (0.46) GRM2CHRM4CAMK2DPARP1FADS1
SCHEMBL2900422 0.94 CAMK2D (0.44) CHRM4CAMK2DPARP1FADS1FYN
SCHEMBL8237810 0.93 GRM2 (0.47) GRM2PARP1FYNPDE1APDE1B
SCHEMBL8234135 0.93 GRM2 (0.47) GRM2PARP1FYNPDE1APDE1B
SCHEMBL2901567 0.93 GRM2 (0.47) GRM2PARP1FYNPDE1APDE1B
SCHEMBL13086254 0.93 KDM4E (0.49) GRM2PARP1FADS1FYNRAD52
SCHEMBL2943578 0.93 KDM4E (0.49) GRM2PARP1FADS1FYNRAD52
SCHEMBL2894075 0.93 KDM4E (0.49) GRM2PARP1FADS1FYNRAD52
SCHEMBL8235890 0.92 CHRM4 (0.50) GRM2CHRM4FADS1KDM4EALDH1A1
SCHEMBL13086150 0.92 CHRM4 (0.50) GRM2CHRM4FADS1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007078523-A2 5-PHENYL-3-BENZYL-0XAZ0LIDIN-2-0NE DERIVATIVES AND RELATED COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2007-07-12 WO disclosed